{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:05:25Z","timestamp":1791317125320,"version":"4.3.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143283","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:38:20Z","timestamp":1448383100000},"page":"e0143283","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":151,"title":["Urinary Volatile Organic Compounds for the Detection of Prostate Cancer"],"prefix":"10.1371","volume":"10","author":[{"given":"Tanzeela","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Aggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"De Lacy Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Persad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Al-Kateb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris S.","family":"Probert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"ref1","unstructured":"NCI, NCIN. Cancer incidence, males, ICD10 C61: Prostate, 2008\u20132010 UK Cancer Information Service (UKCIS); 2013 [updated June 2013; cited 2014 25th July 2014]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncin.org.uk\/cancer_information_tools\/eatlas\/\" xlink:type=\"simple\">http:\/\/www.ncin.org.uk\/cancer_information_tools\/eatlas\/<\/ext-link>."},{"key":"ref2","unstructured":"NCI, (NCIN). Cancer mortality, males, ICD10 C61: Prostate, 2009\u20132011: UK Cancer Information Service (UKCIS); [cited 2014 25th July 2014]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncin.org.uk\/cancer_information_tools\/eatlas\" xlink:type=\"simple\">http:\/\/www.ncin.org.uk\/cancer_information_tools\/eatlas<\/ext-link>."},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-4295(00)00637-3","article-title":"Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging","volume":"56","author":"WJ Catalona","year":"2000","journal-title":"Urology"},{"issue":"2","key":"ref4","first-page":"70","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"AM Wolf","year":"2010","journal-title":"CA: a cancer journal for clinicians"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1997.03540420048028","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/mL and benign prostate examination. Enhancement of specificity with free PSA measurements","volume":"277","author":"WJ Catalona","year":"1997","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"22","key":"ref6","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level &lt; or = 4.0 ng per milliliter","volume":"350","author":"IM Thompson","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"WJ Catalona","year":"1994","journal-title":"The Journal of urology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(05)67367-3","article-title":"A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection","volume":"164","author":"CK Naughton","year":"2000","journal-title":"The Journal of urology"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"GL Andriole","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMc1005498","article-title":"Dutasteride and prostate cancer","volume":"363","author":"FH Schroder","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"J Groskopf","year":"2006","journal-title":"Clinical chemistry"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2362.2008.01953.x","article-title":"Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA","volume":"38","author":"R Herwig","year":"2008","journal-title":"European journal of clinical investigation"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","article-title":"Serum isoform [\u20132]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2\u201310 ng\/ml: a multicentric European study","volume":"63","author":"M Lazzeri","year":"2013","journal-title":"European urology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.urology.2007.01.097","article-title":"EPCA-2: a highly specific serum marker for prostate cancer","volume":"69","author":"ES Leman","year":"2007","journal-title":"Urology"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.juro.2008.08.119","article-title":"Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection","volume":"181","author":"M Schostak","year":"2009","journal-title":"The Journal of urology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1158\/1078-0432.CCR-07-0700","article-title":"Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer","volume":"13","author":"D Hessels","year":"2007","journal-title":"Clinical Cancer Research"},{"issue":"94","key":"ref17","doi-asserted-by":"crossref","first-page":"94ra72","DOI":"10.1126\/scitranslmed.3001970","article-title":"Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA","volume":"3","author":"SA Tomlins","year":"2011","journal-title":"Science translational medicine"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0090-4295(98)00245-3","article-title":"In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic &quot;gray zone&quot; of total PSA 4 to 10 ng\/mL","volume":"52","author":"MK Kwiatkowski","year":"1998","journal-title":"Urology"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/1078-0432.CCR-10-2410","article-title":"Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer","volume":"17","author":"R Morgan","year":"2011","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref20","article-title":"Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men","volume":"3","author":"E Killick","year":"2013","journal-title":"Sci Rep-Uk"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","article-title":"Challenges of cancer biomarker profiling","volume":"52","author":"K Bensalah","year":"2007","journal-title":"European urology"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00345-007-0146-y","article-title":"Role of nomograms for prostate cancer in 2007","volume":"25","author":"FK Chun","year":"2007","journal-title":"World journal of urology"},{"issue":"7231","key":"ref23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"A Sreekumar","year":"2009","journal-title":"Nature"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2010.01.035","article-title":"Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours","volume":"58","author":"F Jentzmik","year":"2010","journal-title":"European urology"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1258\/acb.2010.009270","article-title":"Serum sarcosine is not a marker for prostate cancer","volume":"47","author":"EA Struys","year":"2010","journal-title":"Annals of Clinical Biochemistry"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00216-011-5098-9","article-title":"GC\/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization","volume":"401","author":"H Wu","year":"2011","journal-title":"Analytical and bioanalytical chemistry"},{"issue":"1\u20132","key":"ref27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.applanim.2004.04.008","article-title":"Evidence for canine olfactory detection of melanoma","volume":"89","author":"D Pickel","year":"2004","journal-title":"Appl Anim Behav Sci"},{"issue":"7468","key":"ref28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/bmj.329.7468.712","article-title":"Olfactory detection of human bladder cancer by dogs: proof of principle study","volume":"329","author":"CM Willis","year":"2004","journal-title":"Bmj"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1534735405285096","article-title":"Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers","volume":"5","author":"M McCulloch","year":"2006","journal-title":"Integr Cancer Ther"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1534735408319058","article-title":"Human ovarian carcinomas detected by specific odor","volume":"7","author":"G Horvath","year":"2008","journal-title":"Integr Cancer Ther"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.eururo.2010.10.006","article-title":"Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis","volume":"59","author":"JN Cornu","year":"2011","journal-title":"European urology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2490-14-22","article-title":"Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a double-blind, controlled trial of prostate cancer detection","volume":"14","author":"KR Elliker","year":"2014","journal-title":"BMC urology"},{"key":"ref33","first-page":"e546","article-title":"PD19-01 Prostate cancer urine detection through highly-trained dogs&apos; olfactory system: a real clinical opportunity","author":"G Taverna","year":"2014","journal-title":"American Urological Association 109th Annual Meeting; April 2014; Orlando, Florida, USA: The Journal of Urology"},{"key":"ref34","article-title":"Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study","author":"A Roine","year":"2014","journal-title":"The Journal of urology"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/pcan.2014.11","article-title":"Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study","volume":"17","author":"AD Asimakopoulos","year":"2014","journal-title":"Prostate Cancer P D"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/2\/3\/037022","article-title":"A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry","volume":"2","author":"S Smith","year":"2008","journal-title":"J Breath Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4939-1258-2_17","article-title":"Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs)","volume":"1198","author":"S Zhang","year":"2014","journal-title":"Methods Mol Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.talanta.2011.12.041","article-title":"Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers\u2014a powerful strategy for breast cancer diagnosis","volume":"89","author":"CL Silva","year":"2012","journal-title":"Talanta"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-4347(00)00554-5","article-title":"Headspace solid-phase microextraction profiling of volatile compounds in urine: application to metabolic investigations","volume":"753","author":"GA Mills","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"16","key":"ref40","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/bioinformatics\/btr379","article-title":"Metab: an R package for high-throughput analysis of metabolomics data generated by GC-MS","volume":"27","author":"R Aggio","year":"2011","journal-title":"Bioinformatics"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature Selection with the Boruta Package","volume":"36","author":"MB Kursa","year":"2010","journal-title":"J Stat Softw"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"28","author":"M Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"ref43","first-page":"71","article-title":"Discriminant analysis","author":"WR Klecka","year":"1980"},{"issue":"1\u20132","key":"ref44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chemolab.2006.04.021","article-title":"Reducing over-optimism in variable selection by cross-model validation","volume":"84","author":"E Anderssen","year":"2006","journal-title":"Chemometr Intell Lab"},{"issue":"3\u20134","key":"ref45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cem.1225","article-title":"Repeated double cross validation","volume":"23","author":"P Filzmoser","year":"2009","journal-title":"J Chemometr"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1468-0394.2008.00480.x","article-title":"Analysis of cancer data: a data mining approach","volume":"26","author":"D Delen","year":"2009","journal-title":"Expert Syst"},{"key":"ref47","first-page":"1833","article-title":"Permutation Tests for Studying Classifier Performance","volume":"11","author":"M Ojala","year":"2010","journal-title":"J Mach Learn Res"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1109\/JSEN.2009.2035771","article-title":"Application of Similarity Coefficients to Predict Disease Using Volatile Organic Compounds","volume":"10","author":"S Smith","year":"2010","journal-title":"Ieee Sens J"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjc.6605810","article-title":"Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors","volume":"103","author":"G Peng","year":"2010","journal-title":"British journal of cancer"},{"issue":"127","key":"ref50","doi-asserted-by":"crossref","first-page":"127rv3","DOI":"10.1126\/scitranslmed.3003180","article-title":"Beyond PSA: the next generation of prostate cancer biomarkers","volume":"4","author":"JR Prensner","year":"2012","journal-title":"Science translational medicine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2105-11-468","article-title":"Multivariate meta-analysis of proteomics data from human prostate and colon tumours","volume":"11","author":"LH Rosenberg","year":"2010","journal-title":"BMC bioinformatics"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/6\/2\/027108","article-title":"The versatile use of exhaled volatile organic compounds in human health and disease","volume":"6","author":"AW Boots","year":"2012","journal-title":"J Breath Res"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/bjc.2011.437","article-title":"Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry","volume":"105","author":"CL Silva","year":"2011","journal-title":"British journal of cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2867-8-17","article-title":"Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro","volume":"8","author":"W Filipiak","year":"2008","journal-title":"Cancer cell international"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"MJ Roobol","year":"2010","journal-title":"European urology"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","article-title":"A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer","volume":"68","author":"B Laxman","year":"2008","journal-title":"Cancer research"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.juro.2010.12.032","article-title":"A Multicenter Study of [\u20132]P With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng\/ml Prostate Specific Antigen Range","volume":"185","author":"WJ Catalona","year":"2011","journal-title":"J Urology"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2013.12.005","article-title":"Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy","volume":"66","author":"G Lughezzani","year":"2013","journal-title":"European urology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T17:34:43Z","timestamp":1567359283000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143283"}},"subtitle":[],"editor":[{"given":"Franky L","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143283","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}